Main Article Content


Objective: Untreated periodontal disease seems to cause low grade systemic inflammation and blood lipid alteration leading to increased cardiovascular disease risk. To start testing this hypothesis in Colombian patients, a multicentre study was conducted including the three main state capitals: Bogotá, Medellín and Cali.

Methods: In this study 192 (28.4%) advanced and 256 (37.8%) moderate periodontitis patients were  investigated for socio-demographic variables, city of precedence, periodontal parameters, smoking, red complex periodontopathic bacteria, serum antibodies against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans and blood lipids including total cholesterol, HDL, LDL and triglycerides (TG). Those parameters were compared to 229 (33.8%) controls having periodontal health or gingivitis.

Results: Advanced periodontitis had worst periodontal indexes, than moderate periodontitis and controls. Interestingly, higher HDL and TG levels were present in periodontitis. BMI <30 and smoking were associated with increased HDL, HDL-35, LDL and TG, while glycemia >100 mg/dL associated with HDL, HDL-35 and TG. Tannerella forsythia showed a significant association with HDL-35 in bivariate analysis and serum IgG1 against P. gingivalis associated with HDL-35 and serum IgG1 against T. forsythia associated with TG and serum IgG2 against A. actinomycetemcomitans correlated with levels of HDL y HDL-35. In logistic regression the periodontitis patients from Cali presented reduced HDL levels as compared to Bogotá and Medellín patients. Presence of IgG1 antibodies against P. gingivalis and A. actinomycetemcomitans correlated with reduced HDL levels.

Conclusion: This study confirmed that untreated periodontitis generates alteration in serum lipid levels and systemic bacterial exposure against important periodontopathic bacteria seems to be the biological link.


Jaramillo, A., Lafaurie, G. I., Millán, L. V., Ardila, C. M., Duque, A., Novoa, C., López, D., & Contreras, A. (2024). Association between periodontal disease and plasma levels of cholesterol and triglycerides. Colombia Medica, 44(2), 80–86. (Original work published May 31, 2013)

1. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003; 82(2): 82-90.

2. Aiuto, F. D’ , Sabbah W, Netuveli G, Donos N, Hingorani, A. D´, Deanfield J, et al. Association of the Metabolic Syndrome with Severe Periodontitis in a Large U.S. Population-Based Survey. J Clin Endocrinol Metab. 2008; 93(10): 3989-94.

3. Ministerio de Salud de Colombia. III Estudio Nacional de Salud Bucal - ENSAB III. II Estudio Nacional de Factores de Riesgo de Enfermedades Crónicas -ENFREC II: Prevalencia de Diabetes Mellitus y de glucosa alterada en ayunas T. V. 3 ed. Bogotá: Ministerio de Salud de Colombia- Centro Nacional de Consultoría; Bogotá, 1999.

4. WHO . Cardiovascular diseases (CVDs). Geneva: World Health Organization; 2013.

5. Nesbitt MJ, Reynolds MA, Shiau H, Choe K, Simonsick EM, Ferrucci L. Association of periodontitis and metabolic syndrome in the Baltimore Longitudinal Study of Aging. Aging Clin Exp Res. 2010; 22(3): 238-42.

6. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001; 72(9): 1221-7.

7. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12): 836-43.

8. Izumi Y, Nagasawa T, Umeda M, Kobayashi H, Takeuchi Y, Yashiro R, et al. Periodontitis and cardiovascular diseases: The link and relevant mechanisms. Jpn Dent Sci Rev. 2009; 45(2): 98-108.

9. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol. 2000; 27(8): 537-41.

10. Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol. 2000; 73(5): 494-500.

11. Kobayashi Y, Niu K, Guan L, Momma H, Guo H, Cui Y, et al Oral health behavior and metabolic syndrome and its components in adults. J Dent Res. 2000; 91(5): 479-84.

12. Kwon YE, Ha JE, Paik DI, Jin BH, Bae KH. The relationship between periodontitis and metabolic syndrome among a Korean nationally representative sample of adults J Clin Periodontol. 2011; 38(9): 781-6.

13. Machado AC, Quirino MR, Nascimento LF. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz Oral Res. 2005; 19(4): 284-9.

14. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein. In Vivo protection against endotoxin by plasma high density lipoprotein. PNAS. 1993; 90(24): 12040-4.

15. Mackness MI, Durrington PN, Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol. 2000; 11(4): 383-8.

16. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995; 36(2): 211-28.

17. Mendez AJ. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res. 1997; 38(9): 1807-21.

18. van Dam MJ, de Groot E, Clee SM, Hovingh, G Kees, Roelants R, et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet. 2002; 359(9300): 37-42.

19. Sammalkorpi K, Vhighnen V, Kerttula Y, Nikkilä E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 1988; 37(9): 859-65.

20. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993; 76(6): 1423-7.

21. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002; 43(3): 717-31.

22. Newnham HH, Barter PJ. Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high-density lipoproteins during incubation of human plasma. Biochim Biophys Acta. 1990; 1044(1): 57-64.

23. Ard JD, Rosati R, Oddone EZ. Culturally-sensitive weight loss program produces significant reduction in weight, blood pressure, and cholesterol in eight weeks. J Natl Med Assoc. 2000; 92(11): 515-23.

24. Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P. Chlamydia pneumoniae and Helicobacter pylori infections in Sámi and Finnish reindeer herders. Int J Circumpolar Health. 1997; 56(3): 70-5.

25. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol. 2002; 7(1): 79-89.

26. Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, et al. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res. 2003; 45(1): 139-47.


Download data is not yet available.
Received 2012-05-30
Accepted 2013-04-03
Published 2024-06-24